Brief: Neuroscientific Biopharmaceuticals Says Stephen Carter Appointed CEO
31/08/2023 07:53
Aug 31 (Reuters) - NeuroScientific Biopharmaceuticals
Ltd NSB.AX :
* STEPHEN CARTER APPOINTED CEO
* PAUL RENNIE TO STEP DOWN AS INTERIM CEO
Source text for Eikon: ID:nASX2KN0p0
Further company coverage: NSB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neuroscientific Biopharmaceuticals
See all newsBrief: Neuroscientific Biopharmaceuticals Appoints Chris Knee As CFO
Brief: Neuroscientific Biopharmaceuticals Seeks Trading Halt
Australia's NeuroScientific Biopharmaceuticals surges on positive clinical results
Brief: Neuroscientific Biopharmaceuticals Requests Trading Halt
Brief: Neuroscientific Biopharmaceuticals Appoints Nathan Smith As CEO